BIA
HRMY icon

Bell Investment Advisors’s Harmony Biosciences HRMY Stock Holding History

Bell Investment Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23
Closed -$764 – 1928
2025
Q1 		$764 Hold
23
– – ﹤0.01% 1640
2024
Q4 		$792 Buy
+23
New +$790 ﹤0.01% 1653
2024
Q2 		– Sell
-32
Closed -$1.07K – 1951
2024
Q1 		$1.07K Buy
32
+16
+100% +$514 ﹤0.01% 1584
2023
Q4 		$517 Hold
16
– – ﹤0.01% 1824
2023
Q3 		$525 Buy
+16
New +$555 ﹤0.01% 1770
2023
Q2 		– Sell
-11
Closed -$360 – 1952
2023
Q1 		$360 Buy
+11
New +$501 ﹤0.01% 1890

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bell Investment Advisors's HRMY Position: Q2 2025 in Review

Bell Investment Advisors sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 23 shares — an estimated $764 sold.

Bell Investment Advisors first reported a position in HRMY in Q1 2023 and held it in 6 quarters. The position peaked at $1.07K in Q1 2024. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

  • Bell Investment Advisors reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 23 Harmony Biosciences shares in Q2 2025, an estimated $764.
  • Bell Investment Advisors first reported a position in Harmony Biosciences in Q1 2023 and held it in 6 quarters.
  • Bell Investment Advisors's Harmony Biosciences position peaked at $1.07K in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Bell Investment Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.